{"altmetric_id": 87131323, "counts": {"readers": {"citeulike": "0", "mendeley": "118", "connotea": "0"}, "total": {"posts_count": 87}, "twitter": {"unique_users_count": 55, "posts_count": 65}, "news": {"unique_users_count": 19, "unique_users": ["globenewswire", "marketscreener", "forextv", "tcmnet_com", "stockwatch", "crwe_world", "the_street", "morning_star", "vb_profiles", "benzinga", "biz_wire_express", "spoke", "jotup", "biospace", "fierce_health_finance", "technology_networks", "redaccion_medica", "news_24", "new_york_times"], "posts_count": 20}, "blogs": {"unique_users_count": 1, "unique_users": [57867], "posts_count": 1}, "facebook": {"unique_users_count": 1, "unique_users": ["145700222245802"], "posts_count": 1}}, "citation": {"altmetric_jid": "medrxiv", "authors": ["Snyder, Thomas M.", "Gittelman, Rachel M.", "Klinger, Mark", "May, Damon H.", "Osborne, Edward J.", "Taniguchi, Ruth", "Zahid, H. Jabran", "Kaplan, Ian M.", "Dines, Jennifer N.", "Noakes, Matthew T.", "Pandya, Ravi", "Chen, Xiaoyu", "Elasady, Summer", "Svejnoha, Emily", "Ebert, Peter", "Pesesky, Mitchell W.", "Almeida, Patricia De", "O\u2019Donnell, Hope", "DeGottardi, Quinn", "Keitany, Gladys", "Lu, Jennifer", "Vong, Allen", "Elyanow, Rebecca", "Fields, Paul", "Greissl, Julia", "Baldo, Lance", "Semprini, Simona", "Cerchione, Claudio", "Nicolini, Fabio", "Mazza, Massimiliano", "Delmonte, Ottavia M.", "Dobbs, Kerry", "Laguna-Goya, Rocio", "Carre\u00f1o-Tarragona, Gonzalo", "Barrio, Santiago", "Imberti, Luisa", "Sottini, Alessandra", "Quiros-Roldan, Eugenia", "Rossi, Camillo", "Biondi, Andrea", "Bettini, Laura Rachele", "D\u2019Angio, Mariella", "Bonfanti, Paolo", "Tompkins, Miranda F.", "Alba, Camille", "Dalgard, Clifton", "Sambri, Vittorio", "Martinelli, Giovanni", "Goldman, Jason D.", "Heath, James R.", "Su, Helen C.", "Notarangelo, Luigi D.", "Paz-Artal, Estela", "Martinez-Lopez, Joaquin", "Carlson, Jonathan M.", "Robins, Harlan S."], "doi": "10.1101/2020.07.31.20165647", "first_seen_on": "2020-08-04T10:44:42+00:00", "issns": [], "last_mentioned_on": 1621380732, "links": ["https://www.medrxiv.org/content/10.1101/2020.07.31.20165647v1", "https://www.medrxiv.org/content/10.1101/2020.07.31.20165647v1?rss=1%22", "https://www.medrxiv.org/content/10.1101/2020.07.31.20165647v2.full.pdf", "https://www.medrxiv.org/content/10.1101/2020.07.31.20165647v2", "https://www.medrxiv.org/content/10.1101/2020.07.31.20165647v3", "https://www.medrxiv.org/node/97014.external-links.html", "http://medrxiv.org/lookup/doi/10.1101/2020.07.31.20165647", "https://www.medrxiv.org/content/10.1101/2020.07.31.20165647v3?utm_content=buffer05773&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418734/"], "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/08/04/2020.07.31.20165647.full.pdf", "pmid": "32793919", "publisher": "Cold Spring Harbor Laboratory", "title": "Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population Levels", "type": "article", "mendeley_url": "https://www.mendeley.com/catalogue/e4fff374-afb0-3366-accc-d2a46498ca05/"}, "altmetric_score": {"score": 169.1, "score_history": {"1y": 169.1, "6m": 12.6, "3m": 2.35, "1m": 0.85, "1w": 0.85, "6d": 0.85, "5d": 0.85, "4d": 0.85, "3d": 0.85, "2d": 0.85, "1d": 0.85, "at": 169.1}, "context_for_score": {"all": {"total_number_of_other_articles": 17749513, "mean": 9.4534503084126, "rank": 133906, "this_scored_higher_than_pct": 99, "this_scored_higher_than": 17616003, "rank_type": "exact", "sample_size": 17749513, "percentile": 99}, "similar_age_3m": {"total_number_of_other_articles": 303357, "mean": 18.570641363146, "rank": 5262, "this_scored_higher_than_pct": 98, "this_scored_higher_than": 298096, "rank_type": "exact", "sample_size": 303357, "percentile": 98}, "this_journal": {"total_number_of_other_articles": 20259, "mean": 54.661972851572, "rank": 1060, "this_scored_higher_than_pct": 94, "this_scored_higher_than": 19202, "rank_type": "exact", "sample_size": 20259, "percentile": 94}, "similar_age_this_journal_3m": {"total_number_of_other_articles": 917, "mean": 158.49413958561, "rank": 173, "this_scored_higher_than_pct": 81, "this_scored_higher_than": 745, "rank_type": "exact", "sample_size": 917, "percentile": 81}}}, "demographics": {"poster_types": {"member_of_the_public": 35, "researcher": 17, "practitioner": 2, "science_communicator": 1}, "users": {"twitter": {"cohorts": {"Members of the public": 35, "Scientists": 17, "Practitioners (doctors, other healthcare professionals)": 2, "Science communicators (journalists, bloggers, editors)": 1}}, "mendeley": {"by_status": {"Student  > Postgraduate": 6, "Researcher": 27, "Student  > Master": 7, "Student  > Ph. D. Student": 15, "Professor": 8, "Student  > Bachelor": 14, "Student  > Doctoral Student": 6, "Lecturer": 3, "Other": 8, "Librarian": 3, "Professor > Associate Professor": 1, "Unspecified": 3}, "by_discipline": {"Medicine and Dentistry": 29, "Social Sciences": 2, "Physics and Astronomy": 1, "Mathematics": 1, "Environmental Science": 1, "Unspecified": 3, "Chemical Engineering": 1, "Engineering": 3, "Chemistry": 3, "Neuroscience": 1, "Immunology and Microbiology": 18, "Computer Science": 3, "Agricultural and Biological Sciences": 16, "Nursing and Health Professions": 3, "Business, Management and Accounting": 1, "Biochemistry, Genetics and Molecular Biology": 13}}}, "geo": {"twitter": {"US": 24, "GB": 2, "DE": 2, "HU": 1, "SE": 1, "CA": 1, "ES": 3}}}, "posts": {"twitter": [{"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "921400462838042624"}, "tweet_id": "1290599208848969728"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "1239643988707160064"}, "tweet_id": "1290601279945953284"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "247384369"}, "tweet_id": "1290664485410295809"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "971826543457550337"}, "tweet_id": "1290664653035409408"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "577178402"}, "tweet_id": "1290666571514298369"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "728922185281064960"}, "tweet_id": "1290684915353354246"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "1125548944686243842"}, "tweet_id": "1290703367535124480"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "838493077"}, "tweet_id": "1290716911269842945"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "151772758"}, "tweet_id": "1290724897598005248"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "17654724"}, "tweet_id": "1290725348401803264"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "33177553"}, "tweet_id": "1290733845185269761"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "85214700"}, "tweet_id": "1290734645919617024"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "895327979286540288"}, "tweet_id": "1290754217632649216"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "24748398"}, "tweet_id": "1290799332598284289"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "107420642"}, "tweet_id": "1290823037126733824"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "2599010778"}, "tweet_id": "1290852666659110913"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "93589445"}, "tweet_id": "1290861959710089216"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "17788462"}, "tweet_id": "1290864547121823749"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "172648738"}, "tweet_id": "1290873725953482756"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "2165152506"}, "tweet_id": "1290874707449798656"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "557940912"}, "tweet_id": "1290874789842898944"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "1241931876924903425"}, "tweet_id": "1290887586781843456"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "882773529590087680"}, "tweet_id": "1290888859027349509"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "1390276418"}, "tweet_id": "1290901928025755649"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "1248268321251876866"}, "tweet_id": "1290921006354386946"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "1123979285432344577"}, "tweet_id": "1290921224839847936"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "986877320"}, "tweet_id": "1290956234657533953"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1290979600374403078"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1290979622126059520"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "409428830"}, "tweet_id": "1291014197179015168"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "409428830"}, "tweet_id": "1291015007455641600"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "1048339575230218241"}, "tweet_id": "1291420978321346560"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "1267861682631716864"}, "tweet_id": "1292496034904576001"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "1242129012438241284"}, "tweet_id": "1294385031209787394"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "6899782"}, "tweet_id": "1295783303581241346"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "2830215105"}, "tweet_id": "1295787559524503553"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "891902654363955204"}, "tweet_id": "1295791122283991041"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "498631199"}, "tweet_id": "1295792498107772928"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "2241273877"}, "tweet_id": "1295800714359341057"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "2296454820"}, "tweet_id": "1304259578805260293"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "236139265"}, "tweet_id": "1304555656947601409"}, {"license": "gnip", "citation_ids": [89381807, 1531030, 87143200, 88270532, 87131323, 89615526, 88246964], "author": {"tweeter_id": "1232200466148265984"}, "tweet_id": "1305930556866277381"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1306918417652473856"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1306918439974588417"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "69441276"}, "tweet_id": "1307062467063930883"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "161764306"}, "tweet_id": "1312358280971186176"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1319074617072488448"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "2165152506"}, "tweet_id": "1326342840180330496"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "925235691419729921"}, "tweet_id": "1326406595551629313"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "1247317617150328832"}, "tweet_id": "1326412012000251905"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "1477127906"}, "tweet_id": "1326591149134450688"}, {"license": "gnip", "citation_ids": [87131323, 93710293], "author": {"tweeter_id": "2149170848"}, "tweet_id": "1326799148423766019"}, {"license": "gnip", "citation_ids": [87131323, 93710293], "author": {"tweeter_id": "2149170848"}, "tweet_id": "1328779187914727429"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "211353183"}, "tweet_id": "1329414145410732032"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "1020444006"}, "tweet_id": "1354373532566884353"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "1119627253841895424"}, "tweet_id": "1354375787458211840"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "786118672343457793"}, "tweet_id": "1354399602192089094"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "1260207789487665153"}, "tweet_id": "1354436135980834816"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "870959434679410688"}, "tweet_id": "1354495713745448971"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "2984742628"}, "tweet_id": "1368337385566650371"}, {"license": "gnip", "citation_ids": [87131323], "author": {"tweeter_id": "1265336030833422337"}, "tweet_id": "1369334076642004994"}, {"license": "gnip", "citation_ids": [97311126, 87131323, 21792501, 18463085], "author": {"tweeter_id": "69441276"}, "tweet_id": "1369694521529802752"}, {"license": "gnip", "citation_ids": [97311126, 87131323, 21792501, 18463085], "author": {"tweeter_id": "69441276"}, "tweet_id": "1369695064260157444"}, {"license": "gnip", "citation_ids": [97311126, 87131323, 21792501, 18463085], "author": {"tweeter_id": "69441276"}, "tweet_id": "1369699790162903050"}, {"license": "gnip", "citation_ids": [97311126, 87131323, 21792501, 18463085], "author": {"tweeter_id": "1158576502440468480"}, "tweet_id": "1394798002305441794"}], "news": [{"title": "Adaptive Biotechnologies Launches immunoSEQ T-MAP COVID, First Molecular T Cell Monitoring Tool for SARS-CoV-2", "url": "http://ct.moreover.com/?a=42759508188&p=1pl&v=1&x=210uWw5hMijOmy6Ja3Jcag", "license": "public", "citation_ids": [87131323], "posted_on": "2020-08-04T13:30:00+00:00", "summary": "Tailored for vaccine developers to accurately and reproducibly measure and track COVID-19 specific T-cell response in clinical trials Powered by T-cell immune response data from over 1,000 COVID-19 patients from ImmuneCODE, the largest public\u2026", "author": {"name": "GlobeNewswire", "url": "https://www.globenewswire.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/389/normal/B.PNG?1575002884"}}, {"title": "ADAPTIVE BIOTECHNOLOGIES : Launches immunoSEQ T-MAP COVID, First Molecular T Cell Monitoring Tool for SARS-CoV-2", "url": "http://ct.moreover.com/?a=42759514620&p=1pl&v=1&x=n1cX0TRZ5nlxrlrl1rCfsA", "license": "public", "citation_ids": [87131323], "posted_on": "2020-08-04T13:30:03+00:00", "summary": "Tailored for vaccine developers to accurately and reproducibly measure and track COVID-19 specific T-cell response in clinical trials Powered by T-cell immune response data from over 1,000 COVID-19 patients from ImmuneCODE, the largest public\u2026", "author": {"name": "MarketScreener", "url": "https://www.marketscreener.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/689/normal/screen.PNG?1576146564"}}, {"title": "Adaptive Biotechnologies Launches immunoSEQ T-MAP COVID, First Molecular T Cell Monitoring Tool for SARS-CoV-2", "url": "http://ct.moreover.com/?a=42759520409&p=1pl&v=1&x=p2RN-rJh3NSklVYw5OSsBw", "license": "public", "citation_ids": [87131323], "posted_on": "2020-08-04T13:30:00+00:00", "summary": "Tailored for vaccine developers to accurately and reproducibly measure and track COVID-19 specific T-cell response in clinical trials Powered by T-cell immune response data from over 1,000 COVID-19 patients from ImmuneCODE, the largest public\u2026", "author": {"name": "ForexTV", "url": "https://forextv.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/394/normal/Capture_5.PNG?1575004762"}}, {"title": "Adaptive Biotechnologies Launches immunoSEQ T-MAP COVID, First \u2026", "url": "http://ct.moreover.com/?a=42760056188&p=1pl&v=1&x=dr6XUwIJZ8zaI16G_I0cwQ", "license": "public", "citation_ids": [87131323], "posted_on": "2020-08-04T14:50:49+00:00", "summary": "] Tailored for vaccine developers to accurately and reproducibly measure and track COVID-19 specific T-cell response in clinical trials Powered by T-cell immune response data from over 1,000 COVID-19 patients from ImmuneCODE, the largest public\u2026", "author": {"name": "TMCnet.com", "url": "http://www.tmcnet.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/169/normal/Screen_Shot_2014-10-01_at_14.45.46.png?1412171168"}}, {"title": "Adaptive Biotechnologies Launches immunoSEQ T-MAP COVID, First Molecular T Cell Monitoring Tool for SARS-CoV-2", "url": "http://ct.moreover.com/?a=42759532245&p=1pl&v=1&x=CHqa8zga-hnSPjOUbAoXYw", "license": "public", "citation_ids": [87131323], "posted_on": "2020-08-04T13:33:29+00:00", "summary": "Tailored for vaccine developers to accurately and reproducibly measure and track COVID-19 specific T-cell response in clinical trials Powered by T-cell immune response data from over 1,000 COVID-19 patients from ImmuneCODE, the largest public\u2026", "author": {"name": "Stockwatch", "url": "https://www.stockwatch.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/797/normal/Capture19.PNG?1576480973"}}, {"title": "Adaptive Biotechnologies Launches immunoSEQ T-MAP COVID, First Molecular T Cell Monitoring Tool for SARS-CoV-2", "url": "http://ct.moreover.com/?a=42759562126&p=1pl&v=1&x=MlsvU86tCu6y4kGpAfzfIg", "license": "public", "citation_ids": [87131323], "posted_on": "2020-08-04T13:36:56+00:00", "summary": "Tailored for vaccine developers to accurately and reproducibly measure and track COVID-19 specific T-cell response in clinical trials Powered by T-cell immune response data from over 1,000 COVID-19 patients from ImmuneCODE, the largest public\u2026", "author": {"name": "Crwe World", "url": "http://crweworld.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/344/normal/Capture_crwe.PNG?1574923200"}}, {"title": "Adaptive Biotechnologies Launches ImmunoSEQ T-MAP COVID, First Molecular T Cell Monitoring Tool For SARS-CoV-2", "url": "http://ct.moreover.com/?a=42759569352&p=1pl&v=1&x=STJy5wlzpMUpD6Ig8mioWw", "license": "public", "citation_ids": [87131323], "posted_on": "2020-08-04T13:30:31+00:00", "summary": "Tailored for vaccine developers to accurately and reproducibly measure and track COVID-19 specific T-cell response in clinical trials Powered by T-cell immune response data from over 1,000 COVID-19 patients from ImmuneCODE, the largest public\u2026", "author": {"name": "The Street", "url": "http://www.thestreet.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/809/normal/Screen_Shot_2016-01-27_at_10.05.56.png?1453889412"}}, {"title": "Adaptive Biotechnologies Launches immunoSEQ T-MAP COVID, First Molecular T Cell Monitoring Tool for SARS-CoV-2", "url": "http://ct.moreover.com/?a=42759579042&p=1pl&v=1&x=LAmWBpbJW45QUomfk-nTbQ", "license": "public", "citation_ids": [87131323], "posted_on": "2020-08-04T13:30:31+00:00", "summary": "Tailored for vaccine developers to accurately and reproducibly measure and track COVID-19 specific T-cell response in clinical trials Powered by T-cell immune response data from over 1,000 COVID-19 patients from ImmuneCODE, the largest public\u2026", "author": {"name": "Morning Star", "url": "https://www.morningstar.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/002/912/normal/Screen_Shot_2018-09-17_at_18.20.59.png?1537204915"}}, {"title": "Adaptive Biotechnologies Launches immunoSEQ T-MAP COVID, First Molecular T Cell Monitoring Tool for SARS-CoV-2", "url": "http://ct.moreover.com/?a=42759640539&p=1pl&v=1&x=72V5FJpAJZqPqdgJ8awWQw", "license": "public", "citation_ids": [87131323], "posted_on": "2020-08-04T13:48:16+00:00", "summary": "Tailored for vaccine developers to accurately and reproducibly measure and track COVID-19 specific T-cell response in clinical trials Powered by T-cell immune response data from over 1,000 COVID-19 patients from ImmuneCODE, the largest public\u2026", "author": {"name": "VB Profiles", "url": "https://www.vbprofiles.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/839/normal/58.JPG?1576557158"}}, {"title": "Adaptive Biotechnologies Launches immunoSEQ T-MAP COVID, First Molecular T Cell Monitoring Tool for SARS-CoV-2", "url": "http://ct.moreover.com/?a=42759640878&p=1pl&v=1&x=PJbbbVC78Ty7yoTIov4ybQ", "license": "public", "citation_ids": [87131323], "posted_on": "2020-08-04T13:30:31+00:00", "summary": "Tailored for vaccine developers to accurately and reproducibly measure and track COVID-19 specific T-cell response in clinical trials Powered by T-cell immune response data from over 1,000 COVID-19 patients from ImmuneCODE, the largest public\u2026", "author": {"name": "Benzinga", "url": "http://www.benzinga.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/738/normal/Screen_Shot_2016-01-26_at_15.59.27.png?1453824001"}}, {"title": "Adaptive Biotechnologies Launches immunoSEQ T-MAP COVID, First Molecular T Cell Monitoring Tool for SARS-CoV-2", "url": "http://ct.moreover.com/?a=42759672003&p=1pl&v=1&x=K1NDA7UWqzITuiHGf0yJbA", "license": "public", "citation_ids": [87131323], "posted_on": "2020-08-04T13:53:50+00:00", "summary": "Tailored for vaccine developers to accurately and reproducibly measure and track COVID-19 specific T-cell response in clinical trials Powered by T-cell immune response data from over 1,000 COVID-19 patients from ImmuneCODE, the largest public\u2026", "author": {"name": "Biz Wire Express", "url": "http://www.bizwireexpress.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/795/normal/Screen_Shot_2016-01-27_at_09.34.21.png?1453887297"}}, {"title": "Adaptive Biotechnologies Launches immunoSEQ T-MAP COVID, First Molecular T Cell Monitoring Tool for SARS-CoV-2", "url": "http://ct.moreover.com/?a=42759688739&p=1pl&v=1&x=UtIMIvSVLqyYduFQkHkreA", "license": "public", "citation_ids": [87131323], "posted_on": "2020-08-04T13:56:59+00:00", "summary": "Tailored for vaccine developers to accurately and reproducibly measure and track COVID-19 specific T-cell response in clinical trials Powered by T-cell immune response data from over 1,000 COVID-19 patients from ImmuneCODE, the largest public\u2026", "author": {"name": "Spoke", "url": "http://www.spoke.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/787/normal/Capture14.PNG?1576476237"}}, {"title": "Adaptive Biotechnologies Launches immunoSEQ T-MAP COVID, First Molecular T Cell Monitoring Tool for SARS-CoV-2", "url": "http://ct.moreover.com/?a=42760003443&p=1pl&v=1&x=s9Id8KzZF3sToXOz2Ig0tA", "license": "public", "citation_ids": [87131323], "posted_on": "2020-08-04T14:42:43+00:00", "summary": "This reproducible, high-throughput, high resolution, molecular data will be made available through Adaptives existing cloud-based immunoSEQ Analyzer to assist with analysis and visualization of the immune response.", "author": {"name": "Jotup", "url": "https://jotup.co/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/003/231/normal/jotup-logo.png?1567071493"}}, {"title": "Adaptive Biotechnologies Launches immunoSEQ T-MAP COVID, First Molecular T Cell Monitoring Tool for SARS-CoV-2", "url": "http://ct.moreover.com/?a=42760309323&p=1pl&v=1&x=Pf8Nj7GvFk66QrpDZ_5GAQ", "license": "public", "citation_ids": [87131323], "posted_on": "2020-08-04T00:00:00+00:00", "summary": "Tailored for vaccine developers to accurately and reproducibly measure and track COVID-19 specific T-cell response in clinical trials Powered by T-cell immune response data from over 1,000 COVID-19 patients from ImmuneCODE, the largest public\u2026", "author": {"name": "Biospace", "url": "http://www.biospace.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/375/normal/biospace.png?1437140433"}}, {"title": "How Adaptive Biotechnologies and Microsoft are working to 'decode' our immune response to COVID-19", "url": "http://ct.moreover.com/?a=42823321637&p=1pl&v=1&x=5YCyYwLbahqLng4_K4XaOQ", "license": "public", "citation_ids": [87131323], "posted_on": "2020-08-10T21:30:37+00:00", "summary": "Adaptive Biotechnologies and tech giant Microsoft first teamed up in 2018, they were using cloud computing to \u201cdecode\u201d the immune system.", "author": {"name": "Fierce  Health", "url": "http://fiercehealthfinance.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/475/normal/Screen_Shot_2016-01-06_at_14.24.45.png?1452090655"}}, {"title": "Tapping Into Information Locked in Our T Cells To Fight COVID-19", "url": "http://ct.moreover.com/?a=42947355490&p=1pl&v=1&x=bFIkkMUEkVqNw-pvQZ6JOg", "license": "public", "citation_ids": [87131323], "posted_on": "2020-08-28T20:25:42+00:00", "summary": "Credit: Pixabay. Our immune system is instrumental in protecting us from external invaders of every shape and size.", "author": {"name": "Technology Networks", "url": "http://www.technologynetworks.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/002/009/normal/Screen_Shot_2016-02-18_at_10.51.33.png?1455792737"}}, {"title": "El 12 de Octubre se une al desarrollo internacional de un test Covid-19", "url": "http://ct.moreover.com/?a=43327300599&p=1pl&v=1&x=w0MCnCK7u5XJ8BY4Mqvg5A", "license": "public", "citation_ids": [87131323], "posted_on": "2020-10-16T10:49:50+00:00", "summary": "Aporta datos a la base ImmuneCODE que busca el desarrollo de una prueba m\u00e1s precisa a trav\u00e9s de linfocitos T El Hospital Universitario 12 de Octubre de la Comunidad de Madrid colabora con la empresa americana Adaptive Biotechnologies y Microsoft\u2026", "author": {"name": "Redacci\u00f3n M\u00e9dica", "url": "https://www.redaccionmedica.com/"}}, {"title": "Un nouveau type de test pourrait mieux discerner l\u2019immunit\u00e9 au coronavirus", "url": "http://ct.moreover.com/?a=43530986726&p=1pl&v=1&x=0cxFsFvTem-PfJBGK9pWHQ", "license": "public", "citation_ids": [93631693, 88945337, 88641641, 87131323], "posted_on": "2020-11-11T08:53:45+00:00", "summary": "Un nouveau type de test peut mieux d\u00e9tecter la r\u00e9ponse immunitaire d\u2019une personne au coronavirus qu\u2019un test d\u2019anticorps largement utilis\u00e9, selon une \u00e9tude publi\u00e9e mardi.", "author": {"name": "News 24", "url": "https://news-24.fr/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/005/611/normal/NEWS24.PNG?1601112788"}}, {"title": "New Type of Test May Better Discern Immunity to the Coronavirus", "url": "http://ct.moreover.com/?a=43527061382&p=1pl&v=1&x=vE29TJng0y3hR5plgfE2LQ", "license": "public", "citation_ids": [93631693, 88945337, 89409491, 91431152, 94385320, 82372636, 88641641, 87131323, 82300301], "posted_on": "2020-11-10T21:57:56+00:00", "summary": "The test detects the response of T cells to the virus \u2014 an arm of the immune system that may be just as important as antibodies to preventing reinfection.", "author": {"name": "New York Times", "url": "http://www.nytimes.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/022/normal/image.png?1369859672"}}, {"title": "New Type of Test May Better Discern Immunity to the Coronavirus", "url": "http://ct.moreover.com/?a=43527032014&p=1pl&v=1&x=-0TPOG1-cyBKoRIfIiby-A", "license": "public", "citation_ids": [93631693, 88945337, 89409491, 91431152, 94385320, 82372636, 88641641, 87131323, 82300301], "posted_on": "2020-11-10T21:52:28+00:00", "summary": "The test detects the response of T cells to the virus \u2014 an arm of the immune system that may be just as important as antibodies to preventing reinfection.", "author": {"name": "New York Times", "url": "http://www.nytimes.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/022/normal/image.png?1369859672"}}], "blogs": [{"title": "COVID-19 T-cell immune response map, immunoSEQ T-MAP COVID for research of T-cell response to SARS-CoV-2 infection", "url": "https://pharmaceuticalintelligence.com/2020/11/20/covid-19-t-cell-immune-response-map-immunoseq-t-map-covid-for-research-of-t-cell-response-to-sars-cov-2-infection/", "license": "public", "citation_ids": [87875180, 87131323, 84403838], "posted_on": "2020-11-20T17:31:19+00:00", "summary": "COVID-19 T-cell immune response map, immunoSEQ T-MAP COVID for research of T-cell response to SARS-CoV-2 infection Reporter: Aviva Lev-Ari, PhD, RN &#160; Read our latest blog\u00a0&#124;\u00a0T cells: Understanding Exposure and Immunity to COVID-19 by Adaptive Co-F", "author": {"name": "Pharmaceutical Intelligence", "url": "http://pharmaceuticalintelligence.com/", "description": "A blog specializing in Pharmaceutical Intelligence and Analytics"}}], "facebook": [{"url": "https://www.facebook.com/permalink.php?story_fbid=1768526149963193&id=145700222245802", "license": "public", "citation_ids": [87131323], "posted_on": "2021-01-27T10:30:27+00:00", "summary": "\ud83d\udc69\u200d\ud83d\udd2cHoy mi\u00e9rcoles a las 16.00 horas, IV Sesi\u00f3n del #ImmunologyClub de la SEI en la que nos centraremos en el art\u00edculo cient\u00edfico:\n\n\ud83d\udcd1 Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population Levels: ow.ly/GV2U50", "author": {"name": "Sociedad Espa\u00f1ola de Inmunolog\u00eda", "url": "https://www.facebook.com/145700222245802", "facebook_wall_name": "Sociedad Espa\u00f1ola de Inmunolog\u00eda", "image": "https://graph.facebook.com/145700222245802/picture", "id_on_source": "145700222245802"}}]}, "score": 169.1, "images": {"small": "https://badges.altmetric.com/?size=64&score=170&types=mbtttttf", "medium": "https://badges.altmetric.com/?size=100&score=170&types=mbtttttf", "large": "https://badges.altmetric.com/?size=180&score=170&types=mbtttttf"}}